Suhasini Sil: Mitigating Grade III Plateletpheresis Reactions – A Prospective Evaluation
Suhasini Sil, Senior Resident doctor at AIIMS, shared a post on LinkedIn about a recent article she and her colleagues co-authord, published in Transfusion Clinique et Biologique, adding:
“Excited to share our original research is recently accepted for publication in Transfusion Clinique et Biologique
‘Prospective evaluation of pre-procedure education and active monitoring in reducing grade III donor reactions in plateletpheresis’
Key findings:
- Donor education and active monitoring increased ADR detection nearly four-fold (9.3% vs. 2.3%).
- All reactions identified in the intervention group were mild (Grade I), with no Grade II or Grade III reactions observed.
- The odds of severe donor reactions were reduced by 98% with proactive donor engagement.
- Early recognition of symptoms improved donor safety, donor experience, and may support long-term donor retention.
A heartfelt thanks to all co-authors, donors, nursing staff, and colleagues who contributed to this work.”
Title: Prospective evaluation of pre-procedure education and active monitoring in reducing grade III donor reactions in plateletpheresis
Authors: Suhasini Sil, Hem Chandra Pandey, Manvi Talwar, Chanchi Khiamniungan, Lubna Naseer, Poonam Coshic

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines